 |
Emerging Leader Podcast Series 2011
Sponsored By Cegedim Relationship Management
|
Meet this year’s Emerging Pharma Leaders. Can these trendsetters build competitive scale from scarcity? Listen in as 10 of our winners discuss their thoughts on managing in the era of lean.
 |
|
Trends in Assessing Internal and Outsourced Clinical Trial Costs and Resource Demand
Sponsored By ClearTrial
|
Join Reid Paul, Editor in Chief of Pharmaceutical Representative, Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Andy Grygiel, Vice President of Marketing and Product Management at ClearTrial, for Parts 1 and 2 of this podcast series as we discuss recent Tufts research on assessing clinical trial costs and resource demand. In Part 3 of the series, Molly Blake-Michaels, Director, Clinical Services at ClearTrial, will examines the pros and cons of the most widely used clinical trial forecasting and budgeting methods in use today by biopharmaceutical and medical device companies.
|
|
|
Emerging Pharma Leadership Awards 2010
Sponsored By Cegedim Relationship Management
|
Pharm Exec’s third annual Emerging Pharma Leadership Awards podcast series addresses a key issue facing the biopharma industry today and asks the hard question of what are the attributes of effective leadership in organizations that have no choice but to adapt to a changing market environment? Join us as ten winners discuss their thoughts on leadership today.
|
|
Trends in Patient Access: How Health Reform, Cost of Care and Stakeholder Response Will Shape Pharmaceutical Product Utilization
Sponsored By AmerisourceBergen Specialty Group
|
Questions abound over the impact that health reform and related measures will have on patients’ ability to receive the medications they want and need. Join us as we discuss what pharmaceutical manufacturers, payers, providers and patients are doing in response to this dynamic healthcare environment.
|
|
Industry Audit & Company of the Year
Sponsored By Covidien
|
What’s the best managed pharma company? Each year, Professor Bill Trombetta of Saint Joseph’s University attempts to answer the question in Pharm Exec’s “Industry Audit,” applying a battery of traditional and applied metrics to a diverse range of publicly held biotech and big pharma companies.
|
|
Emerging Pharma Leadership Awards
Sponsored By Cegedim Dendrite
|
Pharm Exec’s second annual Emerging Pharma Leadership Awards cast the spotlight on 27 innovative young stars notable for their dedication and contribution to the industry. Listen to interviews with 12 of these 27 innovative executives who are helping take the pharmaceutical industry to the next level.
|
|
The Future of Oncology: How Public Policy, New Technology and Financial Considerations will Impact Cancer Care
Sponsored By AmerisourceBergen Specialty Group
|
With the U.S. healthcare system at an unprecedented crossroads, cancer care has emerged as one of the most hotly debated subjects. Stakeholders include manufacturers, physicians, patients, payers and service providers—even the government itself. And all have their own set of concerns to be addressed.
|
|
The Changing Relationship between Pharma and Managed Care
Sponsored By AmerisourceBergen Specialty Group
|
Once viewed as the enemy, managed care has emerged as a necessary stakeholder and even a customer for pharmaceutical manufacturers and physicians in the specialty space. Join us as we discuss how this changing dynamic is impacting patient access, as well as product success.
|
|
Driving Product Success through Patient Adherence and Compliance
Sponsored By AmerisourceBergen Specialty Group
|
Hear how patient adherence programs can be launched, measured and managed efficiently—with real-world examples of what some manufacturers have done to achieve positive clinical results and product growth.
|
|
HBA's Women Of The Year
Sponsored By Purohit Navigation
|
Don’t miss this Podcast series commemorating the 20th anniversary of HBA’s Woman of the Year Award with interviews spanning two decades of change makers.
|
|
REMS: Is it the end of the world as we know it?
(A two-part series)
Sponsored By AmerisourceBergen Specialty Group
|
Join us as we examine key operational and clinical considerations of successful REMS programs—what makes a program work and what impact it can have.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
